Andere talen Apogee Therapeutics, Inc.

Aandelen

APGE

US03770N1019

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
53,22 ^USD	+0,57%		-1,79%	+90,48%

10/05	APOGEE THERAPEUTICS, INC. : BofA Securities handhaaft koopadvies	ZM
25/03	Apogee Therapeutics kondigt aan dat de eerste deelnemers zijn gedoseerd in de Fase 1-studie met APG808, zijn nieuwe verlengde halveringstijd IL-4Ra-antilichaam voor de behandeling van chronische obstructieve longziekte (COPD) en andere ontstekingsziekten	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference	06/05
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases	25/03
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Ra Antibody for the Treatment of Chronic Obstructive Pulmonary Disease and Other Inflammatory Diseases	25/03
Apogee Therapeutics, Inc.(NasdaqGM:APGE) added to S&P Biotechnology Select Industry Index	18/03
Apogee Closes $483 million Upsized Stock Offering	12/03
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million	12/03
Apogee Therapeutics Prices Upsized $420 Million Share Offering	08/03
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering	08/03
Sector Update: Health Care Stocks Advance Wednesday Afternoon	06/03
Apogee Therapeutics Shares Rise After Jefferies Raises Price Target	06/03
Apogee Therapeutics Unveils $350 Million Share Offering	05/03
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering	05/03
Sector Update: Health Care Stocks Retreating Late Afternoon	05/03
Sector Update: Health Care Stocks Lower Tuesday Afternoon	05/03
Top Midday Gainers	05/03
Sector Update: Health Care	05/03
Apogee Therapeutics Shares Surge After Phase 1 Atopic Dermatitis Trial Data, Wedbush Price Target Raise	05/03
Apogee Therapeutics Says Phase 1 Study of Atopic Dermatitis Drug Candidate Exceeds Objectives	05/03
Apogee Therapeutics' Q4 Net Loss Widens	05/03
Apogee Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Apogee Therapeutics, Inc.

Aandelen

APGE

US03770N1019

Andere talen

Filters